Income Tax Expense (Benefit) of Silo Pharma, Inc. from 30 Sep 2021 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Silo Pharma, Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 30 Sep 2021 to 31 Mar 2023.
  • Silo Pharma, Inc. Income Tax Expense (Benefit) for the quarter ending 31 Mar 2023 was $906,396, a 50% increase year-over-year.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)

Silo Pharma, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $906,396 +$303,487 +50% 01 Jan 2023 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q1 2022 $602,909 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q3 2021 $19,133 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3

Silo Pharma, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2021 $24,876 01 Jan 2021 31 Dec 2021 10-K 24 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.